These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19786463)

  • 1. Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study.
    Klein MB; Saeed S; Yang H; Cohen J; Conway B; Cooper C; Côté P; Cox J; Gill J; Haase D; Haider S; Montaner J; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall M; Walmsley S
    Int J Epidemiol; 2010 Oct; 39(5):1162-9. PubMed ID: 19786463
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database.
    Voirin N; Trépo C; Miailhes P; Touraine JL; Chidiac C; Peyramond D; Livrozet JM; Ritter J; Chevallier P; Fabry J; Allard R; Vanhems P
    J Viral Hepat; 2004 Nov; 11(6):559-62. PubMed ID: 15500557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Natural history of hepatitis C in patients HIV-HCV monoinfected and co-infected].
    Fainboim H; Galdame O; Jmelnitzky A
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S29-31; discussion S74-82. PubMed ID: 16862852
    [No Abstract]   [Full Text] [Related]  

  • 4. [Selection for treatment of hepatitis C co-infected patients for ].
    Findor J; Bessone F; Corti M
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S48-50; discussion S74-82. PubMed ID: 16862860
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
    Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
    J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.
    Cooper CL; Mills E
    Int J STD AIDS; 2007 Aug; 18(8):546-50. PubMed ID: 17686217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV/hepatitis co-infection.
    Rockstroh J
    J HIV Ther; 2007 Mar; 12(1):1. PubMed ID: 17589388
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia.
    Wisaksana R; Indrati AK; Fibriani A; Rogayah E; Sudjana P; Djajakusumah TS; Sumantri R; Alisjahbana B; van der Ven A; van Crevel R
    Addiction; 2010 Jun; 105(6):1055-61. PubMed ID: 20331555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does HCV negatively impact on HIV disease--progression and survival?
    Marco M;
    GMHC Treat Issues; 2001 Apr; 15(4):10-1. PubMed ID: 11590939
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents.
    McCance-Katz EF
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S89-95. PubMed ID: 16265622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of HIV-HCV and HBV-HCV co-infection].
    Jmelnitzky AC; Jorge O; Manero E
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S46-8. PubMed ID: 20214301
    [No Abstract]   [Full Text] [Related]  

  • 12. Mortality among urban drug users and the impact of highly active antiretroviral therapy.
    Celentano DD
    Clin Infect Dis; 2005 Sep; 41(6):873-4. PubMed ID: 16107988
    [No Abstract]   [Full Text] [Related]  

  • 13. HCV/HIV co-infection II: sobriety and treatment.
    Moreno G
    Posit Aware; 2002; 13(2):27-8. PubMed ID: 12001925
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
    Tornero C; Alberola J; Tamarit A; Navarro D
    Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.
    Núñez M; Soriano V
    J Hepatol; 2005 Mar; 42(3):290-2. PubMed ID: 15710208
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users.
    Howard AA; Klein RS; Schoenbaum EE
    Clin Infect Dis; 2003 May; 36(10):1318-23. PubMed ID: 12746779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C management in HIV infection--where is the controversy?
    Dieterich DT
    AIDS Read; 2002 Jan; 12(1):22-3. PubMed ID: 11862657
    [No Abstract]   [Full Text] [Related]  

  • 18. A systematic approach to the treatment of HIV and hepatitis C virus infection in the inner city: a Canadian perspective.
    Conway B; Grebely J; Tossonian H; Lefebvre D; de Vlaming S
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S73-8. PubMed ID: 16265619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment: liver disease in the HIV-infected patient--the courage to treat.
    Dieterich DT
    AIDS Read; 2003 Oct; 13(10):500-1. PubMed ID: 14596228
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.